Raina Biosciences published GEMORNA in Science Magazine one year ago and is now powering over 30 mRNA therapeutic programs across applications.
Published
Signal category
Research & Knowledge
Quote
“One year ago, GEMORNA was published in Science Magazine. Today, it is no longer just a research breakthrough—it is powering more than 30 mRNA therapeutic programs across a broad range of applications.”
— Raina Biosciences team
Company
Raina Biosciences
Generative AI for mRNA therapeutics
- Industry
- Biotechnology Research
- Location
- Cambridge, US
- Company size
- 2 employees
Raina is developing the leading generative-AI-for-RNA platform to generate superior mRNAs with unprecedented translational capacity and stability. We integrate advanced AI and synthetic biology technologies to design the best therapeutic mRNA sequences with massive throughput and speed. Our mission is to accelerate drug discovery timelines and produce best-in-class RNA therapeutics for novel applications. For partnering inquiries email BD@rainabio.com.
Founded 2023